Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: Clinical implications

Tai, YT, Li, XF, Catley, L, Coffey, R, Breitkreutz, I, Bae, J, Song, WH, Podar, K, Hideshima, T, Chauhan, D, Schlossman, R, Richardson, P, Treon, SP, Grewal, IS, Munshi, NC and Anderson, KC (2005) Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: Clinical implications. Cancer Research, 65 24: 11712-11720. doi:10.1158/0008-5472.CAN-05-1657


Author Tai, YT
Li, XF
Catley, L
Coffey, R
Breitkreutz, I
Bae, J
Song, WH
Podar, K
Hideshima, T
Chauhan, D
Schlossman, R
Richardson, P
Treon, SP
Grewal, IS
Munshi, NC
Anderson, KC
Title Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: Clinical implications
Journal name Cancer Research   Check publisher's open access policy
ISSN 0008-5472
Publication date 2005-12-01
Sub-type Article (original research)
DOI 10.1158/0008-5472.CAN-05-1657
Volume 65
Issue 24
Start page 11712
End page 11720
Total pages 9
Language eng
Keyword Natural-Killer-Cells
Growth-Factor Secretion
Non-Hodgkins-Lymphoma
In-Vivo
Therapeutic Applications
Monoclonal-Antibody
Thalidomide Analogs
Interleukin-2
Apoptosis
Cancer
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 117 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 130 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 20 Jul 2013, 04:57:45 EST by System User